April 04, 2019
Allergan Sales is recalling 72 bottles of Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% because of deviations from Current Good Manufacturing Practice regulations, according to the April 3, 2019, US Food and Drug Administration (FDA) Enforcement Report.
Recalled are 5-mL bottles of Combigan (NDC 0023-9211-05) from lot 99946 (Exp. 1/16/21). Bottles affected by the recall were distributed in Tennessee.
Allergan Sales voluntarily initiated the recall March 19, 2019. On March 22, 2019, the FDA designated it Class II. The classification suggests use of the product could cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Combigan is a prescription ophthalmic solution used to reduce pressure in the eye from glaucoma or ocular hypertension.